Please assess the completion status of the following clinical trial:

Trial Title: Fibromyalgia Integrative Training for Teens

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females ages 12-18~* Juvenile fibromyalgia (JFM) diagnosed by a pediatric rheumatologist or pain physician using 2010 American College of Rheumatology (ACR) criteria and confirmation with a tender point exam of ≥ 11 of 18 tender points upon palpation~* Functional Disability Score ≥13 indicating at least moderate disability~* Average pain intensity in the past week ≥ 4 on a 0-10 cm Visual Analog Scale~Exclusion Criteria:~* Comorbid rheumatic disease (e.g., juvenile arthritis, systemic lupus erythematous)~* untreated major psychiatric diagnoses (e.g., major depression, bipolar disorder, psychoses)~* documented developmental delay~* any medical condition determined by their physician to be a contraindication for participation~* on stable medications for 4 weeks prior to enrollment~* currently in CBT or structured physical therapy program

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Fibromyalgia Integrative Training (Type: EXPERIMENTAL): 8 week (16 sessions) combined intervention with cognitive-behavioral therapy and neuromuscular training
- Cognitive Behavioral Therapy (Type: ACTIVE_COMPARATOR): 8 week (16 session) cognitive-behavioral therapy treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).